Giovanni Squadrito Selected Research

Raxofelast

7/2005	Lipid peroxidation inhibition by raxofelast improves angiogenesis and wound healing in experimental burn wounds.
4/2005	Protective effects of antioxidant raxofelast in alcohol-induced liver disease in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Squadrito Research Topics

Disease

14	Infections 01/2019 - 06/2002
12	Liver Diseases (Liver Disease) 01/2022 - 04/2005
9	Fibrosis (Cirrhosis) 01/2022 - 02/2003
6	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 03/2006
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 03/2020
4	Wounds and Injuries (Trauma) 10/2021 - 04/2003
4	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021 - 01/2004
4	Chronic Hepatitis C 01/2021 - 06/2002
4	Viremia 08/2012 - 06/2002
4	Shock 05/2006 - 01/2002
4	Hypotension (Low Blood Pressure) 05/2006 - 01/2002
3	Burns 04/2006 - 04/2003
2	Chronic Renal Insufficiency 05/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2021
2	COVID-19 12/2021 - 01/2021
2	Neoplasms (Cancer) 12/2021 - 01/2004
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021 - 10/2016
2	Inflammation (Inflammations) 10/2021 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2018 - 09/2015
2	Colitis 10/2016 - 01/2016
2	Hepatitis 10/2016 - 03/2002
2	Atrial Fibrillation 03/2016 - 09/2015
2	Chronic Hepatitis B 01/2011 - 01/2009
2	Persistent Infection 02/2003 - 03/2002
2	Hemorrhagic Shock 01/2003 - 01/2002
2	Hypovolemia 01/2003 - 01/2002
1	Osteoporosis 05/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	End Stage Liver Disease 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Thromboembolism 12/2021
1	Hypoxia (Hypoxemia) 10/2021
1	Ischemia 10/2021
1	Atherosclerosis 07/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Postmenopausal Osteoporosis 01/2021

Drug/Important Bio-Agent (IBA)

10	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2004
10	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 06/2002
8	Surface Antigens (Surface Antigen)IBA 01/2022 - 03/2006
8	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
6	Messenger RNA (mRNA)IBA 05/2006 - 01/2002
5	EnzymesIBA 03/2017 - 04/2003
5	NF-kappa B (NF-kB)IBA 05/2006 - 01/2002
4	PCSK9 InhibitorsIBA 01/2022 - 03/2020
4	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006 - 01/2002
4	NF-KappaB Inhibitor alphaIBA 05/2006 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 07/2005 - 01/2002
3	AntigensIBA 01/2022 - 03/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2005
3	AutoantibodiesIBA 10/2016 - 02/2003
3	salicylhydroxamic acid (SHAM)IBA 05/2006 - 01/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2006 - 04/2003
2	SodiumIBA 01/2022 - 10/2016
2	LipidsIBA 11/2021 - 03/2020
2	PolydeoxyribonucleotidesIBA 10/2021 - 01/2016
2	Fibrinogen (Factor I)FDA Link 01/2020 - 03/2005
2	IodineIBA 01/2020 - 09/2015
2	Serum AlbuminIBA 01/2018 - 03/2016
2	flavocoxidIBA 01/2018 - 10/2016
2	dinitrobenzenesulfonic acidIBA 10/2016 - 01/2016
2	2,4-dinitrofluorobenzene sulfonic acidIBA 10/2016 - 01/2016
2	Ethanol (Ethyl Alcohol)IBA 10/2016 - 01/2016
2	Ribavirin (Virazole)FDA LinkGeneric 09/2014 - 01/2006
2	Hepatitis B e AntigensIBA 08/2012 - 03/2002
2	Immunoglobulin M (IgM)IBA 12/2011 - 06/2005
2	Lamivudine (Epivir)FDA Link 01/2011 - 01/2009
2	Transaminases (Aminotransferases)IBA 08/2010 - 06/2005
2	Insulin (Novolin)FDA Link 08/2010 - 03/2005
2	ImmunosorbentsIBA 04/2006 - 04/2003
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2005 - 04/2003
2	NitritesIBA 07/2005 - 04/2003
2	RaxofelastIBA 07/2005 - 04/2005
2	AntioxidantsIBA 04/2005 - 06/2002
1	Vitamin K FDA Link 05/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	GoldIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Proprotein Convertase 9IBA 11/2021
1	Biological ProductsIBA 11/2021
1	CollagenIBA 10/2021
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	olmesartanIBA 07/2021
1	Losartan (Cozaar)FDA LinkGeneric 07/2021
1	Enalapril FDA LinkGeneric 07/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	AlbuminsIBA 01/2021
1	TroponinIBA 01/2021
1	LDL CholesterolIBA 03/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2020
1	oxidized low density lipoproteinIBA 03/2020

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2006
2	Blood Transfusion (Blood Transfusions) 01/2014 - 01/2007
1	Drug Prescriptions 01/2021
1	Inappropriate Prescribing 01/2021